Visceral organ protection in aortic arch surgery: safety of moderate hypothermia

• Published in: European journal of cardio-thoracic surgery Vol. 46; no. 3; pp. 438 - 443
• Main Authors: Pacini, Davide, Pantaleo, Antonio, Di Marco, Luca, Leone, Alessandro, Barberio, Giuseppe, Murana, Giacomo, Castrovinci, Sebastiano, Sottili, Sandra, Di Bartolomeo, Roberto
• Format: Journal Article
• Language: English
• Published: Germany Oxford University Press 01.09.2014
• Subjects: Aged; Aorta, Thoracic - surgery; Aortic Aneurysm - surgery; Aortic Aneurysm - therapy; Biomarkers - blood; Cardiac Surgical Procedures - adverse effects; Cardiac Surgical Procedures - methods; Cardiopulmonary Bypass - adverse effects; Cardiopulmonary Bypass - methods; Female; Humans; Hypothermia, Induced - adverse effects; Hypothermia, Induced - methods; Kidney Diseases - prevention & control; Liver Diseases - prevention & control; Male; Middle Aged; Risk Factors; Time Factors; Visceral protection; Aortic arch repair; Cerebral protection; Aortic aneurysm; Hypothermia
• ISSN: 1010-7940; 1873-734X
• DOI: 10.1093/ejcts/ezt665

OBJECTIVES Although antegrade selective cerebral perfusion (ASCP) provides good brain protection during aortic arch surgery, the issue of distal organ protection during circulatory arrest remains to be clarified. The aim of the study was to retrospectively evaluate the outcome of aortic arch surgery using ASCP at different temperatures, focusing on visceral functions (VFs). METHODS Three hundred and thirty-four patients underwent elective aortic arch surgery using ASCP from November 1996 to March 2011. Those patients without early postoperative low cardiac output syndrome were included. VFs were evaluated by comparing preoperative and postoperative creatinine, aspartate amino transferase, alanine amino transferase and bilirubin. Univariate and multivariate analysis were performed. RESULTS Three hundred and four patients represent the cohort of the study. Deeper systemic hypothermia (≤25°C) (Group A) was used in 194 patients (63.8%) and moderate hypothermia (>25°C) (Group B) in 110 patients (36.2%). The 30-day mortality rate was 3.6% in Group B and 5.2% in Group A (P = NS). Permanent neurological deficits occurred in 4 (3.6%) and in 14 patients (7.2%) of Group A and Group B, respectively (P = NS). Postoperative renal insufficiency requiring dialysis occurred in 6 patients (5.4%) in Group A and in 15 patients (7.7%) in Group B, the differences were not statistically significant. Biochemical markers of VFs increased in the postoperative period without differences between groups. At the multivariate analysis, cardiopulmonary bypass time >180 min (odds ratio (OR) = 2.16) was the only significant risk factor for renal dysfunction with or without liver dysfunction, while cardiopulmonary bypass time longer than 180 min (OR = 2.28) and hypothermia higher than 25°C (OR = 0.54) were found to be independently related to liver dysfunction. CONCLUSIONS Our results confirmed that ASCP with moderate hypothermia at 26°C is a safe method for brain protection. Moreover, during circulatory arrest, moderate hypothermia also offers good protection of visceral organs and it should be preferred for limited periods (<60 min) of visceral ischaemia because it may reduce the systemic inflammatory response and the reperfusion organ injury.